Food-related Quality of Life in Inflammatory Bowel Disease: Development and Validation of a Questionnaire by Hughes, Lyndsay D. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1093/ecco-jcc/jjv192
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Hughes, L. D., King, L. K., Morgan, M. A., Ayis, S. A. M., Direkze, N., Lomer, M., ... Whelan, K. (2015). Food-
related Quality of Life in Inflammatory Bowel Disease: Development and Validation of a Questionnaire. Journal
of Crohn's & colitis, 10(2), 1-8. 10.1093/ecco-jcc/jjv192
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
1 
 
Food-related quality of life in inflammatory bowel disease: development 
and validation of a questionnaire 
Lyndsay D. Hughes1, Laura King2, Myfanwy Morgan3, Salma Ayis3, Natalie Direkze4, 
Miranda C. Lomer2,5,6, James O. Lindsay7,8, Kevin Whelan2 
1. King’s College London, Department of Psychology, London, United Kingdom 
2. King’s College London, Diabetes and Nutritional Sciences Division, London, UK 
3. King’s College London, Health and Social Care Division, London, UK 
4. Frimley Park Hospital NHS Foundation Trust, Dept. of Gastroenterology, Frimley, UK 
5. Guys and St Thomas’ NHS Foundation Trust, Dept. of Nutrition & Dietetics, London, UK 
6. Guys and St Thomas’ NHS Foundation Trust, Dept. of Gastroenterology, London, UK 
7. Barts and the London School of Medicine and Dentistry, Blizard Institute, Queen Mary 
University of London, London, UK 
8. Digestive Diseases Unit, Barts Health NHS Trust, London, UK 
 
Corresponding author and reprint requests: 
Professor Kevin Whelan, King’s College London, 150 Stamford Street, London, SE1 9NH, 
United Kingdom 
Tel: + 44 20 78 48 38 58; e-mail: kevin.whelan@kcl.ac.uk 
 
Short heading: Food-related quality of life in IBD 
Key words: Inflammatory bowel disease; quality of life; questionnaire; nutrition; validation 
Word count: 3632  
  
2 
 
ABSTRACT 
Background and aims 
Psychosocial factors surrounding eating and drinking such as enjoying food, managing 
restrictions and maintaining social relationships remain under-researched in IBD. This study 
aimed to develop and validate a food-related quality of life (FR-QoL) questionnaire to 
systematically measure these issues in the IBD population. 
Methods 
Following semi-structured interviews with 28 IBD patients, 150 potential questionnaire items 
were generated. These were ranked by 100 IBD patients and items were removed based on 
ceiling/floor effects and high inter-item correlations (>0.7), with 41 items being retained. In 
total, 323 IBD patients, 100 asthma patients (chronic disease control) and 117 healthy 
controls completed the FR-QoL questionnaire alongside generic and disease-specific QoL 
and food satisfaction questionnaires. Principle components analysis (PCA), construct and 
discriminant validity and test-retest reliability were calculated. 
Results 
Twelve items were removed following PCA. The reduced questionnaire (FR-QoL-29) 
explained 63.9% of the variance (Cronbach’s α=0.96). FR-QoL-29 correlated significantly 
with generic QoL (r=0.697), depression (r=-0.519), anxiety (r=-0.531) and food satisfaction 
(r=0.701). The FR-QoL-29 sumscores were significantly lower for IBD (89.5, SD 28.6) than 
asthma (125.4, SD 24.1); p<0.001) and healthy volunteers (123.0 (SD 16.5); p<0.001). 
Within IBD, worse food-related QoL was found in those with moderate/high disease activity 
(66.7, SD 22.1) compared to remission/low disease activity (92.5, SD 28.1). Test-retest 
reliability was good (ICC=0.83, 95% CI=0.76:0.88). 
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Conclusions 
The FR-QoL-29 shows good reliability and validity across a range of IBD characteristics. 
This easily administered questionnaire is a useful tool in identifying poor food-related QoL 
and in the future may identify areas for intervention.  
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INTRODUCTION 
Inflammatory bowel disease (IBD) is associated with a significant negative impact on quality 
of life (QoL) both during relapse and remission[1-3]. Poor QoL and psychological distress 
are related to, among others; active gastrointestinal and systemic symptoms,[1, 4] 
embarrassment[5] and social impairment[4]. Despite this, almost half of patients with IBD 
report that their doctor does not ask about the impact of their disease on QoL[3]. 
Malnutrition is a common consequence of IBD[6] and contributes to poor QoL[7, 8]. 
However, in IBD, access to information regarding diet and nutrition is variable[9], addressed 
by clinicians in a minority of patients[10] and focuses more on specific issues such as enteral 
nutrition[10-12] rather than ongoing nutritional management or psychosocial impacts. 
Meanwhile, there is growing evidence that IBD has a significant impact on the psychosocial 
aspects of food, termed food-related QoL which encompasses achieving adequate nutrition, 
deriving pleasure and maintaining social activities through eating and drinking [13-16].  
Although evidence supporting the role of food and drink in IBD aetiology and symptom 
exacerbation is mixed[17], patients have strong beliefs about the role of “trigger 
foods/drinks”. In response many patients make substantial dietary changes [18, 19], including 
omitting specific foods/food groups [20, 21] or severely restricting the quantities 
consumed[14, 20], as coping mechanisms to address the “lifelong struggle” of knowing what 
to eat[22, 23]. Consequently, patients with IBD can feel excluded from social interactions 
involving eating and drinking, resulting in stress and anxiety[14, 24, 25], alienation from 
friends and family[24] and guilt at letting others down[14, 20]. The impact of food restriction 
and social withdrawal has particular relevance in IBD where diagnosis often occurs in young 
adulthood when patients are forming new relationships and building careers. Social isolation 
may contribute to the high rates of depression and anxiety in people with IBD[26, 27].  
5 
 
Despite these numerous qualitative studies demonstrating profoundly impaired food-related 
QoL in IBD, no study has formally assessed the prevalence of these issues or whether 
targeted intervention can reduce its impact. This is undoubtedly due in part to the lack of a 
valid and reliable tool to measure food-related QoL in IBD. Although numerous tools are 
available to screen for malnutrition risk[28], only a small number of questionnaires measure 
the broader psychosocial aspects of eating and drinking, none of which are specific to IBD.   
The aim of this study was to develop and validate a food-related QoL questionnaire 
specifically for patients with IBD. A reliable and valid tool that quantifies this phenomenon 
could be used to measure the prevalence of such problems and to develop and evaluate 
interventions to address them.  
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MATERIALS AND METHODS   
Development of the questionnaire 
Questionnaire items were generated from semi-structured interviews relating to the 
psychosocial aspects of eating and drinking among 28 people with IBD[14]. Verbatim quotes 
were reviewed by a steering group consisting of a gastroenterologist, dietitians, a medical 
sociologist and a psychologist to remove items of low relevance to the phenomenon under 
investigation, to remove duplicate statements and to ensure that the wording of the items was 
appropriate. Three people with IBD, one gastroenterologist, one IBD specialist nurse and one 
health psychologist outside of the research team reviewed the items for readability and small 
changes were made to aid comprehension.  
In order to reduce the number of potential items and to include only those that were of most 
importance, 100 patients with a confirmed diagnosis of IBD were recruited consecutively 
from routine out-patient appointments at IBD clinics in hospitals across London, UK and 
were asked to rate each statement as to:  
(i) whether the issue had been important to them in the past two weeks; and  
(ii) the strength of importance on a five point Likert-type scale.  
An overall “importance score” for each potential item was calculated by multiplying the 
proportion of patients indicating that the item was important (i) by the mean strength of 
importance (ii)[29, 30]. Ceiling and floor effects were investigated and items were removed if 
≥80% of patients responded with the minimum or maximum “importance score”[31]. Inter-
item correlations were calculated for the “importance score” and items with correlations of 
≥0.8 were discussed by the steering group and the item considered to have the best face 
validity was retained.  
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In line with other quality of life measures (e.g. the UK IBD-Q[32]), a two week reference 
point for the food-related QoL questionnaire was used with a five point Likert-type response 
scale ranging from 1 (definitely agree) to 5 (definitely disagree). Questions were phrased 
such that higher scores indicate better food related quality of life.   
Validation of the questionnaire 
A separate sample of IBD patients was recruited consecutively from gastroenterology and 
specialist IBD outpatient clinics covering urban (London, UK) and suburban (South East, 
UK) areas. Efforts were made to sample the entire range of clinical disease by targeting 
clinics for both adult and adolescent IBD and pre- and post-surgery clinics.  Inclusion criteria 
included any patient with a confirmed diagnosis of IBD aged ≥16 years who was able to read 
English and provide informed consent. Patients with either active or inactive disease were 
included. Exclusion criteria were limited to conditions that might impact on normal eating 
behaviour (e.g. currently pregnant or breastfeeding; diagnosed eating disorder; current 
exclusive parenteral or enteral nutrition; or an acute illness in the past month such as common 
cold, influenza, gastroenteritis) and those that might impact on quality of life (e.g. severe 
mental illness). 
Clinical information extracted from medical notes included diagnosis (CD, UC), date of 
diagnosis, and surgery status (no surgery, previous surgery). Disease phenotype (Montreal 
classification), disease activity (Harvey-Bradshaw index for CD[33], Partial Mayo Score for 
UC[34]) and body mass index (BMI) were recorded prospectively. Participants completed the 
newly developed food-related quality of life (FR-QoL) questionnaire. In addition, they 
completed the Satisfaction with Food-related Life Questionnaire (SWFL[35]); the Hospital 
Anxiety and Depression Scale (HADS[36]); The SF-36[37] (general quality of life, recalled 
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over the past four weeks); the UK IBD-Q[32] (disease-specific quality of life); and the 
MUST Nutritional Risk Questionnaire[38] (high, medium or low risk of malnutrition).  
A healthy volunteer control group was recruited as well as a chronic illness control group 
comprising patients with asthma. Asthma was chosen as the chronic illness control to ensure 
that any differences found in responses by IBD patients were specific to the condition itself, 
rather than to having any long term condition[39]. Participants in both control groups were 
≥16 years old, able to read English, consent for themselves and able to eat independently. The 
same exclusion criteria as for the IBD group applied with the additional criteria that the 
control participants had not experienced digestive symptoms in the past month or been 
diagnosed with a gastrointestinal illness at any time. Healthy volunteers were recruited via a 
circular email to staff and students of a university in the same geographical location and 
subsequent snowballing. People with asthma were recruited both through circular email to 
staff and students of the same university and from specialist asthma clinics, in order to recruit 
a range of disease severity and geographic location comparable to the IBD sample. Control 
participants completed the same questionnaires as IBD patients with the exception of disease-
specific quality of life. The asthma group completed the Asthma Control Questionnaire[40] 
and the healthy volunteers completed the SF-36[37] only. 
Local NHS research ethics committee approval was obtained before conducting the study. 
Participants were only recruited after informed consent.  
Psychometric analysis of the questionnaire 
All statistical analysis was performed using SPSS v20 (IBM, United States). 
The underlying factor structure of the questionnaire was identified using Principal 
Components Analysis (PCA) with varimax rotation on the FR-QoL data from IBD patients. 
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PCA is a statistical technique identifying which items fit together to create latent “factors” 
and which items explain the most variance within the scale[41, 42]. Factors were considered 
important if their Eigen value >1.2 and items that did not have a factor loading of at least 0.4 
were considered for removal as this indicates that they were not measuring the intended 
phenomenon i.e., food related QoL[41]. 
Internal consistency relates to whether all items of the scale are reliably measuring the same 
construct. This is assessed by correlating each item with every other item. The test statistic, 
Cronbach’s α, should exceed 0.7 for good internal consistency[43].   
Concurrent validity was established by correlating the FR-QoL sumscore with the IBD-
Q[32], SF-36[37], HADS[36] and SWFL[35] as these separate questionnaires were 
determined to be measuring similar constructs as the FR-QoL and are well validated. 
Pearson’s r correlation co-efficient should be in the order of 0.7 to indicate that the FR-QoL 
questionnaire is measuring a similar construct to these validated questionnaires but that there 
are differences to justify a new measure[44].  
Discriminant validity of the questionnaire was assessed using the “known groups” 
method[45] to determine if the questionnaire differentiates between groups that are 
theoretically expected to differ a priori[46]. The healthy volunteer and asthma control groups 
are expected to score better on FR-QoL than the IBD group. This was analysed using 
ANOVA with Bonferroni adjustment to reduce Type I error. In addition, IBD patients with 
low disease activity are expected to score better than those with high disease activity; these 
two groups were compared via t-test.   
Test-retest reliability was assessed by requesting the first 100 patients with IBD to complete 
the FR-QoL again four weeks later. However, patients were excluded from this analysis if 
during the four week period, they self-reported that their IBD symptoms had improved or 
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worsened; if they had had an acute illness or had been out of their usual routine (e.g. on 
holiday), all of which could impact on psychosocial aspects of eating and drinking and 
therefore result in a legitimate change in FR-QoL responses. Test-retest reliability was 
measured by calculating the intra-class correlation and kappa coefficients of FR-QoL 
sumscores.  
 
  
11 
 
RESULTS 
Questionnaire development 
A total of 148 people with IBD were approached to participate in the questionnaire 
development and 100 (67.6%) subsequently returned a completed questionnaire. Table 1 
summarises the sample characteristics. Mean age of these participants was 43.4 (SD 2.9) 
years, 46% were female, 64% had a diagnosis of CD, 32% UC and 4% indeterminate IBD. A 
total of 34% self-reported active disease and 32% had received IBD-related surgery at some 
point. Demographic characteristics did not differ between responders and non-responders (all 
p>0.05) and the sample was representative of the UK IBD population[47].  
A total of 150 potential items were analysed. The proportion of people who responded that an 
individual item represented an issue that had been important to them in the past two weeks 
(yes/no) ranged from 0.1 to 0.8. The mean item strength scores ranged between 2.1 (SD 1.5) 
and 3.8 (SD 1.6) (minimum 1, maximum 5) and the overall importance scores ranged from 
0.22 to 2.50. These data informed discussion within the steering group of which items should 
be retained.  A total of 41 items were retained for validation (FR-QoL-41).  
Questionnaire validation 
A total of 434 IBD patients consented to participate in the questionnaire validation phase, 
with 323 (74.4%) returning questionnaires, demographic and clinical data for this population 
are shown in table 2. Missing data for each of the items ranged from 1.2-3.7% and was 
missing at random. As such, missing data was handled through listwise deletion whereby 
participants with missing responses were removed from analysis for that questionnaire item.  
There were no differences between responders and non-responders in disease type, proportion 
with moderate/high disease activity (measured via partial Mayo score or Harvey Bradshaw 
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Index), gender, BMI, MUST nutritional risk score, surgery status or years since diagnosis. 
However, responders were significantly older (39.2 (SD 15.4) years) than non-responders 
(37.2 (SD 15.7) years) (p<0.039) and were significantly older at diagnosis (28.1 (SD 14.5) 
years versus 26.4 (SD 15.0) years) (p<0.001). Of the 323 patients with IBD, 133 had UC and 
190 had CD, the mean BMI was in the healthy range (24.5 kg/m2) and the majority (78.3%) 
had a low risk of malnutrition[38]. The mean number of years since diagnosis was 11.0 (SD 
10.8) ranging from less than one year to fifty-five years. The sample was representative of the 
UK IBD population in secondary care[47].  
A total of 100 people with asthma and 117 healthy volunteers were recruited as controls. 
Table 2 shows comparable demographic characteristics across the three groups. The 
proportion of female participants was significantly lower in the IBD group than both the 
asthma (p<0.001) and healthy volunteer (p<0.001) groups, although the latter did not differ 
from each other. The proportion of current smokers was higher in the IBD group than in the 
healthy volunteer group (p=0.06). 
Principle Components Analysis  
Individual items were checked for ceiling/floor effects. Less than 5% of respondents scored 
the highest or lowest possible score on both the initial questionnaire (FR-QoL-41) and the 
reduced questionnaire (FR-QoL-29).  
A Principle Components Analysis (PCA) was carried out on the 41 item questionnaire (FR-
QoL-41) to determine the factor structure and identify any redundant items. A total sample of 
272 gives a cases-per-predictor ratio of 7:1 which is in keeping with rules of thumb for this 
type of analysis[48]. The Kaiser-Mayer-Olkin measure of sampling adequacy (KMO=0.95) 
and Bartlett’s test of sphericity (p<0.001) met the criteria for performing PCA[49]. 
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The initial PCA showed 7 eigen-values >1 which accounted for 68.4% of the variance, 
although factors 6 and 7 had eigen values of 1.17 and 1.06 respectively indicating weak 
factor structures. Items were removed if their factor loading were ≤0.4 as this indicates that 
the item is not strongly associated with the factor being measured (food-related QoL). In 
addition, PCA shows how the internal reliability is affected by removing each item. By using 
an iterative process to remove items that were not strongly and reliably associated with food-
related QoL, the questionnaire became more parsimonious. Table 3 shows successive PCA 
results with the final 29 item questionnaire (FR-QoL-29) having 4 factors and explaining 
63.9% of the variance, indicating that the 12 removed items added little to the explained 
variance and contributed to an unstable factor structure. The final KMO of 0.95, indicates 
that the FR-QoL-29 has a strong factor structure.   
The factor loadings of the FR-QoL-29 are shown in table 4. Factor I appears to measure 
general food-related QoL as all items have factor loadings ≥0.4. Factor II appears to measure 
the cognitive and affective aspects of FR-QoL with items referring to concentration, 
frustration and not knowing which foods will affect symptoms. Factor III refers to the 
positive aspects of eating and drinking. The fourth factor has only two items with factor 
loadings ≥0.4, both of which refer to eating foods that triggered symptoms. Although factors 
II-IV contain items with factor loadings ≥0.4, in all instances these items also load onto factor 
I with a higher factor loading. For this reason, the FR-QoL-29 is treated as a unidimensional 
scale measuring general food related QoL and all subsequent analyses use the sumscore of 
these 29 items.  
To ensure that removal of questionnaire items did not compromise the validity and reliability 
of the FR-QoL questionnaire, analyses were carried out on both the FR-QoL-41 and FR-QoL-
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29 versions. The minimum and maximum possible scores for the FR-QoL-41 were 41 and 
205 respectively and for the FR-QoL-29 were 29 and 145 respectively.  
Internal consistency 
The internal consistency was excellent for both the FR-QoL-41 (Cronbach’s α=0.962) and the 
FR-QoL-29 (Cronbach’s α=0.959). Removal of the items from the FR-QoL-41 did not impact 
on the reliability of the scale.  
Concurrent Validity 
Mean sumscores for the FR-QoL-41 and FR-QoL-29 significantly correlated with sumscores 
of the IBD-Q[32], HADS[36] and SWFQ[35] in the direction and magnitude that would be 
expected (table 5). Better food related QoL (higher sumscores on the FR-QoL-29) correlated 
with better disease-specific quality of life (IBD-Q, r=0.697) and better food satisfaction 
(SWFL, r=0.701) and correlated negatively with anxiety (HADS-Anxiety subscore, r=-0.531) 
and depression (HADS-depression subscore, r=-0.519). The strength of the correlation did 
not differ between these measures and the FR-QoL-41 and the FR-QoL-29.   
Discriminant validity 
For the IBD group only, patients were dichotomised as having remission/mild or 
moderate/high disease activity using scores of ≥8 on the Harvey Bradshaw Index for CD[50] 
and ≥5 for the partial Mayo Score for UC[51]. The FR-QoL-41 successfully discriminated 
between patients with different disease activity. Therefore, patients with moderate/high 
disease activity had a significantly lower score (96.9 (SD 29.6)) on the FR-QoL-41 than those 
with remission/low disease activity (133.8 (SD 35.9); t(265)=5.56, p<0.001). The same was 
true for the FR-QoL-29; patients with moderate/high disease activity had a significantly 
lower score (66.7 (SD 22.1)) compared to those with remission/low disease activity (92.5 (SD 
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28.1); t(278)=5.14. p<0.001). As expected, there were no differences in FR-QoL-29 scores 
between those with UC or CD (t(283)=1.63, p=0.104). 
For the FR-QoL-29 sumscores, one-way ANOVA with Bonferroni adjustment between the 
IBD (N=314), asthma (N=100) and healthy volunteer (N=117) groups was significant (F(2,478) 
= 101.29, p<0.001), with food-related QoL being significantly lower in patients with IBD 
(mean=89.5 (SD 28.6)) compared to both the asthma (mean=125.4 (SD 24.1); p<0.001) and 
healthy control groups (mean=123.0 (SD 16.5); p<0.001) (Figure 1). In contrast, scores of the 
FR-QoL-29 did not differ significantly between the asthma and healthy control groups 
(p=1.00) indicating that the questionnaire has excellent discriminant validity. The same 
pattern of results was found for the FR-QoL-41, as seen in Figure 1.  
FIGURE 1 AROUND HERE 
Test-retest reliability 
Analysis was performed on 63 IBD patients who reported no change in their IBD symptoms 
in the 4 weeks after completing the first FR-QoL questionnaire. There were no significant 
differences between demographic characteristics of patients who were and were not included 
in the analysis. Food-related QoL remained stable over 4 weeks with the correlation between 
first and second completion for the FR-QoL-41 (r=0.806) and FR-QoL-29 (r=0.833). The 
intraclass correlation coefficient for the FR-QoL-29 was 0.83 (95% CI=0.76:0.88) indicating 
good reliability of the measure over time.   
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DISCUSSION 
Recent research has highlighted the importance of psychosocial factors relating to food in the 
lives of people with IBD[13, 14, 20-23].  Currently, no tool is available to measure the 
prevalence and magnitude of this issue or to assess the impact of any therapeutic intervention 
designed to alleviate it. This study aimed to develop and validate a food-related QoL 
questionnaire for use in both the IBD clinic as well as research trials.  
The PCA resulted in a 29 item questionnaire (FR-QoL-29) explaining 63.9% of the variance. 
The loss of only 4% of the variance and 3 factors after removing 12 items from the FR-QoL-
41 indicates that these items were not adequately measuring food-related QoL. The internal 
consistency of the final FR-QoL-29 was excellent. The factor loading matrix (table 4) shows 
that all items load highly onto the first factor, suggesting an overall “generic” food-related 
QoL factor that all items are measuring and as such, the sumscore of the FR-QoL-29 should 
be used in subsequent studies.  
Principle components analysis was used to reduce the number of items in the questionnaire 
and determine the underlying factor structure. PCA follows classical test theory which 
assumes that the true score is a combination of the observed (or test) score and the error 
associated with answering that question. The assumption is that the true and error scores are 
uncorrelated, i.e. that no one item is more difficult to answer than other (resulting in more 
error across a sample). We chose to follow classical test theory over the more recently 
introduced item response theory as the FR-QoL questionnaire is designed to be used in its 
entirety rather than as individual items and that there is no causal link between the items and 
the underlying construct, both of which are assumptions of item response theory. Due to the 
underlying model of classical test theory, it is also possible to use a smaller sample as long as 
it is representative of the population, which is the case in the current study.  
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Validity of the questionnaire was tested in a number of ways and was shown to be highly 
favourable. The FR-QoL-29 had good discriminant validity, suggesting that it is measuring a 
phenomenon related to living with IBD, rather than simply to experiencing a long term 
condition. The direction and magnitude of the correlations between the FR-QoL-29 and a 
number of food-related, generic and disease-specific QoL measures indicated good 
concurrent validity. The moderate to strong correlations indicate that a construct similar to, 
but unique from, food satisfaction, disease activity and overall QoL is being measured by the 
FR-QoL-29.  
Previous research indicates that both the nutritional and psychosocial aspects of eating and 
drinking are important to people with IBD[13, 25]. Family celebrations and religious 
occasions have been reported as being “no longer joyful” because of food restrictions related 
to fear of relapse[14, 24], whilst the uncertainty of the impact of eating on bowel function can 
restrict travel[23] and autonomy due to the perceived need to be near a toilet[14, 24]. The 
inclusion of items relating to socialising and the cognitive and emotional factors related to 
eating and drinking in IBD therefore allows for these important constructs to be measured in 
a valid way for the first time. Generic QoL as measured by the SF-36[37] is known to be 
lower in long term conditions including IBD than the healthy population[52]. Interventions 
targeting poor QoL in IBD have so far focused on stress management,[53, 54] however they 
have ignored the potential stressors around eating and drinking and the use of unmonitored 
dietary changes as a mechanism for coping with symptoms in IBD[18, 19].  
The FR-QoL-29 was stable over time with excellent test re-test reliability in participants who 
reported no change in their IBD symptoms over four weeks. This, coupled with the 
significantly lower scores reported by IBD patients compared to controls suggests that food-
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related QoL is an important and ongoing issue in IBD, supporting previous qualitative 
research highlighting this issue[14, 20-23].  
No differences in either validity or reliability were found between the FR-QoL-41 and the 
FR-QoL-29. As the 29 item version is briefer and does not compromise the explained 
variance, the final version of the questionnaire includes 29 items, measured on a 5 point 
Likert-type response scale ranging from 1 (definitely agree) to 5 (definitely disagree). 
The questionnaire benefitted from the items being developed directly from verbatim quotes 
from people with IBD discussing the psychosocial issues around eating and drinking ensuring 
it is grounded in what is important to IBD patients. The sample of IBD patients in both the 
development and validation of the questionnaire was large and representative of the 
outpatient population across the spectrum of disease activity and experience to ensure 
generalisability. A limitation of the study is that participants in the validation sample 
completed the entire 41 item version and the items that were subsequently removed could 
have had priming effects on the answers to the retained items, affecting the scores that were 
given. Further validation using the final 29 item version should be carried out with 
confirmatory factor analysis to ensure that the favourable validity and reliability remains.  
The FR-QoL-29 questionnaire is a short, self-report questionnaire that has demonstrated good 
reliability and validity in measuring the psychosocial aspects of eating and drinking in IBD. 
During this initial development and validation of the questionnaire, it was not possible to 
establish the responsiveness of the questionnaire to detect a change or to determine the 
minimal important change[55]. The next steps will be to identify how food-related QoL is 
related to the patients’ clinical condition and the ability of the FR-QoL-29 to detect this, in 
order to develop an appropriate intervention to address this important but under-
acknowledged patient-related outcome.  
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Table 1: Demographics of patients with IBD involved in the selection of items during 
the questionnaire development phase 
 Total N=100 
Disease type, n (%)  
      Crohn’s disease  64 (64) 
      Ulcerative Colitis  32 (32) 
      Indeterminate IBD 4 (4) 
Female gender, n (%) 46 (46) 
Surgery, n (%) 32 (32) 
Self-reported active disease, n (%) 34 (34) 
Previous history of dietary treatment for IBD, n (%) 18 (18) 
Age, years  
      Mean (SD) 40.9 (16.1) 
      Median (range) 37.0 (17.0-82.0) 
Age at diagnosis, years  
      Mean (SD) 28.6 (16.2) 
      Median (range) 24.5 (4.0-79.0) 
Years since diagnosis, mean (SD) 17.8 (2.4) 
BMI, mean (SD)  24.8 (2.9) 
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Table 2: Demographics of patients with IBD, asthma and healthy volunteers involved in 
the questionnaire validation  
 Total IBD 
(N=323) 
Ulcerative 
colitis 
(N=133) 
Crohn’s 
disease 
(N=190) 
Asthma 
(N=100) 
Healthy 
Volunteers 
(117) 
Gender, n (%)      
     Female  163 (50.5)a,b 66 (49.6) 97 (51.1) 72 (72)a 88 (75.2)b 
     Male 156 (48.5) 66 (49.6) 90 (47.4) 38 (38) 29 (24.8) 
     Missing 4 (1.2) 1 (0.8) 3 (1.6) 0 (0) 0 (0) 
Age      
      Mean (SD) 39.2 (15.4) 41.2 (16.4) 37.4 (14.4) 39.2 (15.3) 37.03 (13.8) 
      Median (range) 35.0 (17-81) 37.0 (17-81) 33.5 (17-78) 37 (17-75) 33 (16.-75) 
BMI, kg/m2      
      Mean (SD) 24.5 (4.7) 24.3 (4.5) 24.6 (4.8) 25.0 (6.6) 23.8 (4.0) 
      Median (range) 23.8  
(15.8-43.5) 
23.8  
(15.8-41.5) 
23.8  
(16.2-43.5) 
24.0  
(18.3-43.5) 
23.1  
(16.9-35.8) 
Nutritional risk (MUST), n (%)     
      Low risk 253 (78.3) 106 (79.7) 147 (77.4) - - 
      Medium risk 46 (14.2) 15 (11.3) 31 (16.3) - - 
      High risk 24 (7.4) 12 (9.0) 12 (6.3) - - 
Smoking, n (%)      
      Never smoked 179 (55.4) 72 (54.1) 107 (56.3) 70 (70.0) 89 (76.1_ 
      Previously  102 (31.6) 51 (38.3) 51 (26.8) 24 (24.0) 22 (18.8) 
      Currently  37 (11.5) 9 (6.8) 28 (14.7) 5 (5.0) 6 (5.1) 
      Missing 5 (1.5) 1 (0.8) 4 (2.1) 1 (1.0) 0 (0.0) 
Prior surgery, n (%)      
      Yes 110 (34.1) 14 (10.5) 96 (50.5) - - 
      No 210 (65.0) 118 (88.7) 92 (48.4) - - 
      Missing 3 (0.9) 1 (0.8) 2 (1.1) - - 
Years diagnosed      
      Mean (SD) 11.0 (10.8) 9.0 (9.1) 12.3 (11.6) - - 
      Median (range) 8.0 (0.25-55) 6.0 (0.25-45) 10.0 (0.25-55) - - 
      Missing, n (%) 7 (2.2) 3 (2.3) 4 (2.1) - - 
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Age at diagnosis      
Mean (SD) 28.1 (14.5) 31.9 (16.8) 24.4 (12.3) - - 
Median (range) 24.0 (1.0-80.0) 30.0 (1.0-80.0) 22.0 (6.0-70.7) - - 
a,b p<0.001 
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Table 3: Results of the principle components analysis of the FR-QoL-41 undergoing 
systematic item removal 
Scale Items removed KMO Factors 
remaining 
Variance 
explained, % 
Cronbach’s α Cronbach’s α 
item deleted 
FR-QOL-41 - 0.950 7 68.35 0.962 40 
FR-QOL-40 40 0.951 7 68.64 0.963 2, 3, 10, 34, 38 
FR-QOL-39 10 0.950 7 69.06 0.963 2, 3, 33, 34, 38 
FR-QOL-37 12, 20  
(healthy eating) 
0.952 6 67.51 0.962 2, 3 
FR-QOL-35 15, 25 (toilet) 0.951 6 67.75 0.961 - 
FR-QOL-34 34 0.952 5 65.39 0.961 - 
FR-QOL-33 33 0.952 5 66.00 0.961 - 
FR-QOL-32 13 0.952 5 66.15 0.960 2, 3 
FR-QOL-31 3 0.951 4 63.79 0.960 2 
FR-QOL-30 9 0.950 4 63.72 0.959 - 
FR-QOL-29 2 0.949 4 63.93 0.959 - 
KMO, Kaiser-Meyer-Olkin measure of sampling adequacy 
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Table 4: Item factor loadings of the FR-QoL-29 in patients with IBD 
 
In the past two weeks I II III IV 
... I have regretted eating and drinking things which 
have made my IBD symptoms worse 
.608 .187 .183 .514 
... my enjoyment of a particular food or drink has been 
affected by the knowledge that it might trigger my IBD 
symptoms 
.659 -.024 -.034 .371 
... my IBD has meant that I have had to leave the table 
while I am eating to go to the toilet 
.593 .271 .358 -.206 
... I have not been able to predict how long it will take 
for my body to respond to something I have had to eat 
or drink due to my IBD 
.599 .418 -.131 .042 
... certain foods have triggered symptoms of my IBD .702 .031 .073 .458 
... my IBD has meant that I have been nervous that if I 
eat something I will need to go to the toilet straight 
away 
.696 .216 .259 -.106 
... I have avoided having food and drink I know does 
not agree with my IBD 
.543 -.424 -.050 .278 
... I have felt relaxed about what I can eat and drink 
despite my IBD 
.635 .164 .338 .108 
...I have felt in control of what I eat and drink in 
relation to my IBD 
.580 .289 .312 .029 
... I have struggled to eat the way that is best for my 
IBD because of other commitments during the day 
.619 .120 -.108 .148 
... I have been frustrated about not knowing how food 
and drink will react with my IBD 
.653 .403 -.361 .026 
... I have had to concentrate on what I have been eating 
and drinking because of my IBD 
.775 -.281 -.143 .070 
... I have been worried that if I eat I will get symptoms 
of my IBD 
.771 .188 .085 .061 
... I have felt the way that I eat and drink for my IBD 
has affected my day to day life 
.789 -.055 .008 -.170 
... the way I have had to eat for my IBD has restricted 
my lifestyle 
.799 -.054 .077 -.279 
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... I have had to concentrate on what food I buy 
because of my IBD 
.755 -.407 -.076 .025 
... it has been on my mind how my IBD will be 
affected by what I eat and drink 
.816 -.011 -.186 -.105 
... my IBD has prevented me from getting full pleasure 
from the food and drink I have had 
.817 -.003 .130 -.100 
... I have felt that I need to know what is in the food I 
am eating due to my IBD 
.670 -.399 -.080 .001 
... I have felt that I have to be careful about when I 
have eaten because of my IBD 
.800 -.213 -.025 -.191 
...I have had to be more aware of what I am eating due 
to my IBD 
.796 -.338 -.19 .044 
... I’ve missed being able to eat or drink whatever I 
want because of my IBD 
.832 -.209 -.007 .036 
... I have felt that I would like to be able to eat and 
drink like everyone else 
.771 -.078 .003 -.056 
... I have been happy to eat and drink around people I 
do not know despite my IBD 
.525 .117 .456 -.246 
... I have felt that I have been eating and drinking 
normally despite my IBD 
.624 -.091 .409 -.008 
... I have found it hard not knowing if a certain food 
will trigger IBD symptoms 
.558 .416 -.517 -.006 
... my IBD has meant I have had to make an effort to 
get all the nutrients my body needs 
.489 -.207 -.352 -.160 
... I have felt that I haven't known how my IBD will 
react to food or drink 
.589 .429 -.428 -.095 
... my IBD has meant that I have had to work hard to 
fit my eating habits in around my activities during the 
day 
.705 -.040 -.070 -.296 
Factor loadings >0.4 appear in bold 
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Table 5: Correlation between mean sumscores of both the FR-QoL-41 and the FR-QoL-
29 and demographic, clinical and quality of life measures in patients with IBD 
Correlation with: Pearson correlation co-efficient 
 FR-QoL-41 FR-QoL-29  
Age 0.122* 0.147* 
Gender (0=male, 1=female) -0.219** -0.244** 
Body mass index (BMI) 0.006 -0.001 
Disease type (0=UC, 1=CD) -0.115 -0.096 
Years since diagnosis 0.089 0.105 
Surgery (0=no surgery, 1=surgery) -0.120* -0.089 
Disease activity (0=remission/low, 1=moderate/high) -0.323** -0.294** 
Food satisfaction (SWFL) 0.736** 0.701** 
Anxiety (HADS) -0.540** -0.531** 
Depression (HADS) -0.550** -0.519** 
Disease-specific QoL (IBD-Q) 0.731** 0.697** 
General QoL (SF-36) 0.554** 0.517 
 SF36 physical functioning 0.424** 0.392** 
 SF36 role limitation-physical 0.495** 0.475** 
 SF36 role limitation-emotional 0.464** 0.453** 
 SF36 energy/fatigue 0.512** 0.499** 
 SF36 emotional wellbeing 0.461** 0.445** 
 SF36 social functioning 0.536** 0.511** 
 SF36 pain 0.511** 0.482** 
*p<0.05; **p<0.001 
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Figure Legends: 
 
 
Figure 1: Mean (SD) food-related quality of life sumscores for patients with IBD, 
asthma and healthy volunteers.  
Values are mean sumscores for the FR-QoL-41 (dark grey) and the FR-QoL-29 (light grey) 
comparing patients with IBD (N=314), asthma (N=100) and healthy volunteers (N=117). 
Error bars are +/- 1 SD. One-way ANOVA with Bonferroni adjustment indicates lower 
scores for FR-QoL-29 in patients with IBD (mean=89.5, SD 28.6) compared to asthma 
(mean=125.4, SD 24.1; p<0.001) and healthy volunteers (mean=123.0, SD 16.5; p<0.001). 
